AbbVie (ABBV) Non-Current Deferred Tax Liability (2012 - 2026)
AbbVie's Non-Current Deferred Tax Liability came in at $2.28 billion for Q2 2026, down 10.8% from $2.55 billion a year earlier and down 2.4% from the prior quarter.
AbbVie (ABBV) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie's Non-Current Deferred Tax Liability was $2.39 billion, down 7.4% from FY2024.
- Non-Current Deferred Tax Liability carries a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- Going back by year, Non-Current Deferred Tax Liability was $2.58 billion in FY2024 (+32.1%), $1.95 billion in FY2023 (-10.9%), $2.19 billion in FY2022 (-27.2%) and $3.01 billion in FY2021 (-17.5%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Deferred Tax Liability since Q4 2023.
- Year-over-year, Non-Current Deferred Tax Liability has declined for six consecutive quarters, with growth averaging 2.2% over the last eight quarters.
- The fastest year-over-year change in Non-Current Deferred Tax Liability over five years came in Q3 2024 (growth of 34.5%), and the weakest in Q3 2022 (a decline of 45.3%).
- Business Quant data shows ABBV's Non-Current Deferred Tax Liability at $2.33 billion (Q1 2026), $2.39 billion (Q4 2025) and $2.48 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Bn |
| Mar 31, 2026 | 2.33 Bn |
| Dec 31, 2025 | 2.39 Bn |
| Sep 30, 2025 | 2.48 Bn |
| Jun 30, 2025 | 2.55 Bn |
| Mar 31, 2025 | 2.58 Bn |
| Dec 31, 2024 | 2.58 Bn |
| Sep 30, 2024 | 2.75 Bn |
| Jun 30, 2024 | 2.73 Bn |
| Mar 31, 2024 | 2.72 Bn |
| Dec 31, 2023 | 1.95 Bn |
| Sep 30, 2023 | 2.04 Bn |
| Jun 30, 2023 | 2.12 Bn |
| Mar 31, 2023 | 2.11 Bn |
| Dec 31, 2022 | 2.19 Bn |
| Sep 30, 2022 | 1.97 Bn |
| Jun 30, 2022 | 2.26 Bn |
| Mar 31, 2022 | 2.83 Bn |
| Dec 31, 2021 | 3.01 Bn |
| Sep 30, 2021 | 3.60 Bn |
AbbVie Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();